Overview Latest Regional Industry Featured Multimedia Other Languages Public Company News
All APAC Global
All APAC Global
All APAC Global
All APAC Global
EmeTerm Smart and HeadaTerm 2 Achieve Health Canada MDL Certification 2024-10-16 21:30
Copper-67 SAR-bisPSMA updates 2024-10-16 21:03
IGCS Late Breaking Abstract and The Lancet: Akeso Published Positive PFS and OS Results from Phase 3 First-Line Study of Cadonilimab in Cervical Cancer 2024-10-16 19:02
TenNor Announces More than 300 Million RMB Financing to Support Development and Commercialization of Late-Stage Assets Including Rifasutenizol for Heliobacter pylori Infections 2024-10-16 18:00
Join the GenScript Biotech Global Forum: Unlocking Innovations in Cell and Gene Therapies 2024-10-16 17:43
SONIRE's HIFU Therapy System Designated as Breakthrough Device by FDA 2024-10-16 14:00
PharmAust affirms corporate strategy with name change to Neurizon Therapeutics 2024-10-16 04:14
Chiglitazar for the Treatment of MASH Phase II Clinical Study Selected for Oral Presentation at the 2024 American Liver Disease Annual Meeting 2024-10-15 22:08
Neurophet-AriBio to develop 'Next-Gen Platform for Alzheimer's diagnosis' 2024-10-15 21:00
Bloomage Debuts New Products at CPHI Milan to Reinforce Its Commitment to Innovation 2024-10-15 21:00
PharmAbcine Announces Safety Approval for 4mg Single-dose Cohort in Phase 1 Clinical Trial of PMC-403 for Neovascular Age-related Macular Degeneration 2024-10-15 09:51
Positive guidance from the U.S. FDA on 64Cu-SAR-bisPSMA Phase III trial in patients with recurrence of prostate cancer 2024-10-14 21:02
Tsingke Shines at Cell & Gene Therapy International 2024 2024-10-14 20:11
US FDA issues Study May Proceed letter for the Pilot Study of Pidnarulex Pharmacodynamics in Patients with Advanced Solid Tumors, Sponsored by the US National Cancer Institute 2024-10-14 19:00
Samsung Biologics launches high-concentration formulation platform to accelerate high-dose drug development 2024-10-14 19:00
Baird Medical to Participate in the American Thyroid Association (ATA) Annual Meeting 2024-10-14 17:00
BioCity will present the late-breaking clinical trial data of its ETA selective antagonist SC0062 at the American Society of Nephrology (ASN) 2024 with simultaneous publication of the trial data in the Journal of the American Society of Nephrology (JASN) 2024-10-14 15:38
Zhejiang Taimei Medical Technology Co., Ltd. Is Now Listed on HKEX 2024-10-14 10:18
Modern Meadow Appoints David Williamson as CEO 2024-10-14 09:00
Akeso Secures $250 Million USD to Propel Global Expansion of Its Innovative Drug Pipeline 2024-10-13 20:27
1 6 7 8 9 10 431